Patents by Inventor J. Oliver Dolly

J. Oliver Dolly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Activatable clostridial toxins
    Patent number: 8273358
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: August 15, 2008
    Date of Patent: September 25, 2012
    Assignee: Allergan, Inc.
    Inventors: Lance E. Steward, Joseph Francis, Ester Fernandez-Salas, Sanjiv Ghanshani, Marcella A. Gilmore, Shengwen Li, J. Oliver Dolly, Kei Roger Aoki
  • Activatable recombinant neurotoxins
    Patent number: 8211671
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: July 22, 2008
    Date of Patent: July 3, 2012
    Assignee: Allergan, Inc.
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • Activatable recombinant neurotoxins
    Patent number: 8119370
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: February 21, 2012
    Assignee: Allergan, Inc.
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • Activatable clostridial toxins
    Patent number: 8071110
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: August 15, 2008
    Date of Patent: December 6, 2011
    Assignee: Allergan, Inc.
    Inventors: Lance E. Steward, Joseph Francis, Ester Fernandez-Salas, Sanjiv Ghanshani, Marcella A. Gilmore, Shengwen Li, J. Oliver Dolly, Kei Roger Aoki
  • Activatable recombinant neurotoxins
    Patent number: 8003351
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: August 23, 2011
    Assignee: Allergan, Inc.
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • Activatable recombinant neurotoxins
    Patent number: 7985411
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: August 18, 2008
    Date of Patent: July 26, 2011
    Assignee: Allergan, Inc.
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • Activatable recombinant neurotoxins
    Patent number: 7959933
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: July 30, 2008
    Date of Patent: June 14, 2011
    Assignee: Allergan, Inc.
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • Activatable clostridial toxins
    Patent number: 7897157
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: August 27, 2007
    Date of Patent: March 1, 2011
    Assignee: Allergan, Inc.
    Inventors: Lance E. Steward, Joseph Francis, Ester Fernandez-Salas, Sanjiv Ghanshani, Marcella A. Gilmore, Shengwen Li, J. Oliver Dolly, Kei Roger Aoki
  • Activatable clostridial toxins
    Patent number: 7749514
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: August 27, 2007
    Date of Patent: July 6, 2010
    Assignee: Allergan, Inc.
    Inventors: Lance E. Steward, Joseph Francis, Ester Fernandez-Salas, Marcella A. Gilmore, Shengwen Li, J. Oliver Dolly, Kei Roger Aoki
  • Activatable clostridial toxins
    Patent number: 7740868
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: June 22, 2010
    Assignee: Allergan, Inc.
    Inventors: Lance E. Steward, Joseph Francis, Ester Fernandez-Salas, Sanjiv Ghanshani, Marcella A. Gilmore, Shengwen Li, J. Oliver Dolly, Kei Roger Aoki
  • Activatable recombinant neurotoxins
    Patent number: 7709228
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: July 24, 2007
    Date of Patent: May 4, 2010
    Assignee: Allergan, Inc.
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • ACTIVATABLE RECOMBINANT NEUROTOXINS
    Publication number: 20090087458
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: July 22, 2008
    Publication date: April 2, 2009
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • ACTIVATABLE RECOMBINANT NEUROTOXINS
    Publication number: 20090081730
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: August 18, 2008
    Publication date: March 26, 2009
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • ACTIVATABLE CLOSTRIDIAL TOXINS
    Publication number: 20090069238
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: August 15, 2008
    Publication date: March 12, 2009
    Applicant: Allergan, Inc.
    Inventors: Lance E. Steward, Joseph Francis, Ester Fernandez-Salas, Sanjiv Ghanshani, Marcella A. Gilmore, Shengwen Li, J. Oliver Dolly, Kei Roger Aoki
  • ACTIVATABLE RECOMBINANT NEUROTOXINS
    Publication number: 20090042270
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: August 22, 2008
    Publication date: February 12, 2009
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • ACTIVATABLE RECOMBINANT NEUROTOXINS
    Publication number: 20090030188
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: August 21, 2008
    Publication date: January 29, 2009
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • ACTIVATABLE RECOMBINANT NEUROTOXINS
    Publication number: 20090030182
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: August 22, 2008
    Publication date: January 29, 2009
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • ACTIVATABLE CLOSTRIDIAL TOXINS
    Publication number: 20090018081
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: August 15, 2008
    Publication date: January 15, 2009
    Applicant: ALLERGAN, INC.
    Inventors: Lance E. Steward, Joseph Francis, Ester Fernandez-Salas, Marcella A. Gilmore, Shengwen Li, J. Oliver Dolly, Kei Roger Aoki
  • ACTIVATABLE CLOSTRIDIAL TOXINS
    Publication number: 20090005313
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: August 15, 2008
    Publication date: January 1, 2009
    Inventors: Lance E. Steward, Joseph Francis, Ester Fernandez-Salas, Marcella A. Gilmore, Shengwen Li, J. Oliver Dolly, Kei Roger Aoki
  • ACTIVATABLE CLOSTRIDIAL TOXINS
    Publication number: 20090004224
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: August 15, 2008
    Publication date: January 1, 2009
    Applicant: Allergan, Inc.
    Inventors: Lance E. Steward, Jospeh Francis, Ester Fernandez-Salas, Marcella A. Gilmore, Shengwen Li, J. Oliver Dolly, Kei Roger Aoki